![Fernando Doñate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Fernando Doñate worked as the Director of Preclinical Research at Proacta, Inc. from 2008 to 2010.
He also worked as the Associate Director of Biology at Attenuon, LLC.
Dr. Doñate earned a doctorate degree from the University of Missouri in 1994 and an undergraduate degree from Universidad Complutense de Madrid in 1988.
Eerdere bekende functies van Fernando Doñate
| Bedrijven | Functie | Einde |
|---|---|---|
Attenuon, LLC
 Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Corporate Officer/Principal | - |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Fernando Doñate
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Develops drugs to treat cancer | Health Technology |
Attenuon, LLC
Attenuon, LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develop new generation cancer therapeutics | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Complutense de Madrid
 Universidad Complutense de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
